Molecular Targets and Cancer Therapeutics Conference Moves Targeting KRAS to the Fore
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
Providing a forum for innovative cancer researchers around the world, Singapore will hold its 11th Frontiers in Cancer Science...
The women bustle around a warm, colorful kitchen, making tamales for an upcoming family party. A woman in her...
Since its inception in 1993, the American Association of Cancer Research (AACR) Grants Program, in partnership with other nonprofit...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved wrapped...
In the effort to include more diverse patient populations in clinical trials, good intentions can easily go awry. Panelists...
The injustices come in many ways. A transgender woman is admitted to the hospital for cancer treatment. Her physicians...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved kicked...
In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....